Market Value246,253,014
Total Holdings55
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BCAB / BioAtla, Inc.
ITOS / iTeos Therapeutics, Inc.
OCUL / Ocular Therapeutix, Inc.
CRL / Charles River Laboratories International, Inc.
VTR / Ventas, Inc.
MRTX / Mirati Therapeutics, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
BAX / Baxter International Inc.
RCUS / Arcus Biosciences, Inc.
OPCH / Option Care Health, Inc.
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
ABOS / Acumen Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
ARWR / Arrowhead Pharmaceuticals, Inc.
INVACARE CORP / NOTE 5.000%11/1 (461203AL5)
LLY / Eli Lilly and Company
BMY / Bristol-Myers Squibb Company
TAK / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
OMI / Owens & Minor, Inc.
RLMD / Relmada Therapeutics, Inc.
US461203AJ08 / INVACARE CORPORATION
OHI / Omega Healthcare Investors, Inc.
BDSX / Biodesix, Inc.
CNC / Centene Corporation
STRO / Sutro Biopharma, Inc.
HCA / HCA Healthcare, Inc.
VCYT / Veracyte, Inc.
AZYO / Aziyo Biologics Inc - Class A
PEAK / Healthpeak Properties, Inc.
MMSI / Merit Medical Systems, Inc.
CYTK / Cytokinetics, Incorporated
SILK / Silk Road Medical, Inc
TERN / Terns Pharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
SBRA / Sabra Health Care REIT, Inc.
EHC / Encompass Health Corporation
ICLR / ICON Public Limited Company
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
CANO / Cano Health, Inc.
ATNX / Athenex Inc
AVTR / Avantor, Inc.
XRAY / DENTSPLY SIRONA Inc.
INBX / Inhibrx Biosciences, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
OYST / Oyster Point Pharma Inc
TMO / Thermo Fisher Scientific Inc.
HUM / Humana Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
NTLA / Intellia Therapeutics, Inc.
ALBO / Albireo Pharma Inc
BMEA / Biomea Fusion, Inc.
AXSM / Axsome Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
BMRN / BioMarin Pharmaceutical Inc.
SELB / Selecta Biosciences Inc
TXG / 10x Genomics, Inc.
PCVX / Vaxcyte, Inc.
ELV / Elevance Health, Inc.
GRTS / Gritstone bio, Inc.
VKTX / Viking Therapeutics, Inc.
LH / Labcorp Holdings Inc.
BDX / Becton, Dickinson and Company
MRK / Merck & Co., Inc.
PTCT / PTC Therapeutics, Inc.
CTLT / Catalent, Inc.
CI / The Cigna Group
BIO / Bio-Rad Laboratories, Inc.
IGMS / IGM Biosciences, Inc.
THC / Tenet Healthcare Corporation
COR / Cencora, Inc.
QGEN / Qiagen N.V.
MCK / McKesson Corporation
ETNB / 89bio, Inc.
INSM / Insmed Incorporated
ATNM / Actinium Pharmaceuticals, Inc.
ZTS / Zoetis Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)